Literature DB >> 29957905

Effect on platelet aggregation activity: extracts from 31 Traditional Chinese Medicines with the property of activating blood and resolvingzzm321990stasis.

Cen Chen, Fengqin Wang, Wen Xiao, Zhining Xia, Guang Hu, Jianbo Wan, Fengqing Yang.   

Abstract

OBJECTIVE: To evaluate the anti-platelet aggregation effects of extracts from 31 Traditional Chinese Medicines (TCM) with the property of activating blood and resolving stasis in terms of TCM theory.
METHODS: The 31 TCMs extracts were prepared using water, 90% ethanol and ethyl acetate., and the effects on anti-platelet aggregation were tested on a platelet aggregation analyzer in vitro with adenosine 5'-diphosphate, bovine thrombin and arachidonic acid (AA) as aggregation inducers, respectively. Aspirin was the positive control.
RESULTS: Lots of the tested TCMs had inhibitory effects with concentration-dependent manner on platelet aggregations induced by various agonists. Especially, some of the TCMs such as Chuanxiong (Rhizoma Chuanxiong), Yanhusuo (Rhizoma Corydalis Yanhusuo) and Danshen (Radix Salviae Miltiorrhizae) showed good anti-platelet aggregation effect similar or higher than that in positive control group.
CONCLUSION: The study provided scientific references that several TCMs such as Chuanxiong (Rhizoma Chuanxiong), Yanhusuo (Rhizoma Corydalis Yanhusuo) and Danshen (Radix Salviae Miltiorrhizae), possess the property of anti-platelet aggregation.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29957905     DOI: 10.1016/s0254-6272(17)30028-6

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN: 0255-2922            Impact factor:   0.848


  8 in total

1.  Characterization of thrombin/factor Xa inhibitors in Rhizoma Chuanxiong through UPLC-MS-based multivariate statistical analysis.

Authors:  Yi-Yao Yang; Zhao-Yu Wu; Fang-Bo Xia; Hao Zhang; Xu Wang; Jian-Li Gao; Feng-Qing Yang; Jian-Bo Wan
Journal:  Chin Med       Date:  2020-08-31       Impact factor: 5.455

2.  Comparing coagulation activity of Selaginella tamariscina before and after stir-frying process and determining the possible active constituents based on compositional variation.

Authors:  Qian Zhang; Ya-Li Wang; Die Gao; Liang Cai; Yi-Yao Yang; Yuan-Jia Hu; Feng-Qing Yang; Hua Chen; Zhi-Ning Xia
Journal:  Pharm Biol       Date:  2018-12       Impact factor: 3.503

3.  Assessing the Effectiveness of Direct Data Merging Strategy in Long-Term and Large-Scale Pharmacometabonomics.

Authors:  Xuejiao Cui; Qingxia Yang; Bo Li; Jing Tang; Xiaoyu Zhang; Shuang Li; Fengcheng Li; Jie Hu; Yan Lou; Yunqing Qiu; Weiwei Xue; Feng Zhu
Journal:  Front Pharmacol       Date:  2019-02-20       Impact factor: 5.810

Review 4.  Mechanism of Improving Aspirin Resistance: Blood-Activating Herbs Combined With Aspirin in Treating Atherosclerotic Cardiovascular Diseases.

Authors:  Yixi Zhao; Shengjie Yang; Min Wu
Journal:  Front Pharmacol       Date:  2021-12-17       Impact factor: 5.810

5.  Screening of Potential Thrombin and Factor Xa Inhibitors from the Danshen-Chuanxiong Herbal Pair through a Spectrum-Effect Relationship Analysis.

Authors:  Xu Wang; Dai-Yan Zhang; Shi-Jun Yin; Hui Jiang; Min Lu; Feng-Qing Yang; Yuan-Jia Hu
Journal:  Molecules       Date:  2021-12-01       Impact factor: 4.411

Review 6.  Research Advances in Cardio-Cerebrovascular Diseases of Ligusticum chuanxiong Hort.

Authors:  Dan Li; Yu Long; Shuang Yu; Ai Shi; Jinyan Wan; Jing Wen; Xiaoqiu Li; Songyu Liu; Yulu Zhang; Nan Li; Chuan Zheng; Ming Yang; Lin Shen
Journal:  Front Pharmacol       Date:  2022-01-31       Impact factor: 5.810

7.  Amides, Isoquinoline Alkaloids and Dipeptides from the Aerial Parts of Piper mullesua.

Authors:  Meng-Yuan Xia; Jun Yang; Pan-Hua Zhang; Xiao-Nian Li; Ji-Feng Luo; Chun-Lin Long; Yue-Hu Wang
Journal:  Nat Prod Bioprospect       Date:  2018-08-02

8.  Haemostatic Nanoparticles-Derived Bioactivity of from Selaginella tamariscina Carbonisata.

Authors:  Yusheng Zhao; Yue Zhang; Hui Kong; Meiling Zhang; Jinjun Cheng; Juan Luo; Yan Zhao; Huihua Qu
Journal:  Molecules       Date:  2020-01-21       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.